| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 40.1934 | 7 |
| GSM780708 | Untreated after 4 days (C2_1) | 45.7273 | 31 |
| GSM780709 | Untreated after 4 days (C3_1) | 51.0084 | 51 |
| GSM780719 | Untreated after 4 days (C1_2) | 38.0935 | 3 |
| GSM780720 | Untreated after 4 days (C2_2) | 42.2552 | 14 |
| GSM780721 | Untreated after 4 days (C3_2) | 47.8246 | 40 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 52.7581 | 56 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 52.0373 | 54 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 53.8527 | 58 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 46.4976 | 34 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 44.045 | 22 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 53.2045 | 57 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 49.5936 | 47 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 53.5745 | 57 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 53.5916 | 57 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 49.288 | 46 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 45.7284 | 31 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 53.8661 | 58 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 64.0847 | 67 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 59.9904 | 64 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 57.3266 | 62 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 54.2128 | 58 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 56.7089 | 62 |